Search results (8346)
« Back to PublicationsGenetic Risk and Prognosis of the First Incident Stroke Survivors: Findings from China Kadoorie Biobank and UK Biobank.
Han Y. et al, (2025), Neurology, 105
Individual Participant Level Meta-Analysis Of The Effects Of Empagliflozin On Conventional And Exploratory Acute And Chronic Kidney Outcomes
HERRINGTON W. et al, (2025), The Lancet Diabetes and Endocrinology
Individual Participant Level Meta-Analysis Of The Effects Of Empagliflozin On Conventional And Exploratory Acute And Chronic Kidney Outcomes
HERRINGTON W. et al, (2025), The Lancet Diabetes and Endocrinology
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).
Belij-Rammerstorfer S. et al, (2025), EBioMedicine, 118
Active Monitoring for AtriaL FIbrillation (AMALFI): rationale, protocol, and pilot for a pragmatic, randomized, controlled trial of remote screening for asymptomatic atrial fibrillation
WIJESURENDRA R. et al, (2025), American Heart Journal
The use of fenofibrate in diabetic retinopathy: narrative review
PREISS D. et al, (2025), Journal of Diabetes and its Complications
Contrasting associations of blood lipids with risk of myocardial infarction in Chinese and European adults
CHEN Z. et al, (2025), European Heart Journal
Contrasting associations of blood lipids with risk of myocardial infarction in Chinese and European adults
CHEN Z. et al, (2025), European Heart Journal Open
Do pregnant people have opportunities to participate in clinical trials? an exploratory survey of NIHR HTA-funded trialists.
Burrow R. et al, (2025), Trials, 26
Assessing the value of linking public health microbiology data to the UK Biobank
Lin S-K. et al, (2025)
Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety.
Dědečková K. et al, (2025), Radiother Oncol, 208
Human mobility-based spatial decay models of unsafe and safe water usage in rural Uganda
Reitzug F. et al, (2025)
Inclusion of under-served groups in trials: an audit at a UK primary care clinical trials unit.
Burrow R. et al, (2025), Trials, 26
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
Zhou J. et al, (2025), EClinicalMedicine